SCHEMBL28618898

SCHEMBL28618898

CC(C)(C)OC(=O)NCCCCC(N)C(=O)N1CCC(NC(N)=O)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.46
POLB P06746 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
EPHX1 P07099 1/20 0.43
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
MEN1 O00255 7/20 0.41
KMT2A Q03164 7/20 0.41
GAA P10253 1/20 0.41
ALDH1A1 P00352 1/20 0.41
DPP8 Q6V1X1 3/20 0.40
DPP9 Q86TI2 2/20 0.40
MAPT P10636 1/20 0.40
DPP7 Q9UHL4 4/20 0.39
ITGB3 P05106 2/20 0.39
ITGA2B P08514 2/20 0.39
DPP4 P27487 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28269377 0.94 TDP1 (0.47) TDP1POLBNPSR1EPHX1MAOA
SCHEMBL28269379 0.94 TDP1 (0.47) TDP1POLBNPSR1EPHX1MAOA
SCHEMBL28629697 0.92 EPHX1 (0.48) TDP1POLBNPSR1EPHX1MAOA
SCHEMBL28581494 0.90 EPHX1 (0.46) TDP1POLBNPSR1EPHX1MAOA
SCHEMBL19708437 0.90 EPHX1 (0.46) TDP1POLBNPSR1EPHX1MAOA
SCHEMBL28628321 0.89 EPHX1 (0.48) TDP1POLBNPSR1EPHX1MAOA
SCHEMBL21009781 0.89 EPHX1 (0.46) TDP1POLBNPSR1EPHX1MAOA
SCHEMBL28610942 0.85 POLB (0.43) TDP1POLBNPSR1MAOAMAOB
SCHEMBL28169257 0.84 POLB (0.40) TDP1POLBNPSR1MAOAMAOB
SCHEMBL28619779 0.83 EPHX2 (0.49) TDP1POLBNPSR1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107098871-B Phenyl propionamide derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2021-07-02 CN disclosed